Latest filing published 11 Mar 2024 for Intra-Cellular Therapies, Inc..
Filing timeline
BuySaleInsider track record
Lawrence J. Hineline: trading record in brief
All filings by Lawrence J. Hineline on record concern Intra-Cellular Therapies, Inc., in the capacity of finance chief. The record holds 135 filings, for trades running from 8 September 2014 to 11 March 2024.
Sales make up the whole of the open-market record (81 sales, €32.4M). Besides market trades, the filings include 5 share grants and 45 option exercises. Since January 2024: no purchases and 14 sales on the market.
The latest filing, published on 11 March 2024, reports an option exercise in Intra-Cellular Therapies, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Lawrence J. Hineline
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,582 sharesCommon StockSEC:0000950170-24-029582:2
- 6,618 shares@ US$66.931.1% of flowCommon StockSEC:0000950170-24-029582:1
- 4,453 shares@ US$65.280.7% of flowCommon StockSEC:0000950170-24-029582:3
- 1,100 shares@ US$66.540.2% of flowCommon StockSEC:0000950170-24-029582:4
- 29 shares@ US$67.320.0% of flowCommon StockSEC:0000950170-24-029582:5
- 4,539 shares@ US$56.730.6% of flowCommon StockSEC:0000950170-24-029582:6
- 4,475 shares@ US$66.470.7% of flowCommon StockSEC:0000950170-24-029582:7
- 64 shares@ US$67.120.0% of flowCommon StockSEC:0000950170-24-029582:8
- 6,514 shares@ US$66.268.2% of flowCommon StockSEC:0000950170-24-029582:0
- 13,132 sharesCommon StockSEC:0000950170-24-028819:0
- 300 shares@ US$68.330.0% of flowCommon StockSEC:0000950170-24-021569:1
- 6,867 shares@ US$69.381.2% of flowCommon StockSEC:0000950170-24-021569:2
- 288 shares@ US$70.150.0% of flowCommon StockSEC:0000950170-24-021569:3
- 5,882 shares@ US$36.890.5% of flowCommon StockSEC:0000950170-24-021569:4
- 5,282 shares@ US$69.470.9% of flowCommon StockSEC:0000950170-24-021569:5
- 600 shares@ US$69.810.1% of flowCommon StockSEC:0000950170-24-021569:6
- 7,455 sharesCommon StockSEC:0000950170-24-021569:0
- 10,998 shares@ US$66.611.8% of flowCommon StockSEC:0000950170-24-011392:1
- 185 shares@ US$67.350.0% of flowCommon StockSEC:0000950170-24-011392:2
- 11,183 shares0Common StockSEC:0000950170-24-011392:0
- 44,035 shares@ US$64.376.9% of flowCommon StockSEC:0001209191-23-037968:5
- 3,592 shares@ US$65.010.6% of flowCommon StockSEC:0001209191-23-037968:6
- 25,082 shares@ US$23.941.5% of flowCommon StockSEC:0001209191-23-037968:1
- 11,762 shares@ US$36.891.0% of flowCommon StockSEC:0001209191-23-037968:2
- 4,538 shares@ US$56.730.6% of flowCommon StockSEC:0001209191-23-037968:3
25 of 135 declarations
